Molecular analyses have confirmed the high expression levels of ROR1 mRNA in human ovarian cancer biopsies compared to normal ovary samples and suggested ROR1 as a TAA and a promising therapeutic target for this type of neoplasm (81). The gene discussed is ROR1; the disease is neoplasm.